The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
In health economics, costs can be divided into both direct and indirect categories. Direct costs tend to consist of medical costs, which are those directly attributed to health care interventions (e.g., hospitalizations, pharmaceuticals, devices), and non-medical direct costs such as monitoring and...
Saved in:
Main Authors: | Christopher A. Jones, David G. Chapman, Peter Weimersheimer, Luca Fernandez, Oscar Alejandro Mesa, Christian Peters, Bart M. Vanaudenaerde, Mitchell C. Norotsky, Robin Vos |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2016-06-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9815 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia
by: Ahmet B. Ergin, et al.
Published: (2012-01-01) -
Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia
by: E. Vandeix, et al.
Published: (2012-01-01) -
Polyarteritis Nodosa and Bronchiolitis Obliterans with Organizing Pneumonia, an Unusual Association
by: Kaberi Dasgupta, et al.
Published: (1997-01-01) -
Association between Polyunsaturated Fatty Acid Profile and Bronchial Inflammation in Bronchiolitis Obliterans
by: Silvija P. Jerkic, et al.
Published: (2023-01-01) -
Effect of Maintenance Azithromycin on Established Bronchiolitis Obliterans Syndrome in Lung Transplant Patients
by: Nancy R Porhownik, et al.
Published: (2008-01-01)